Senior insider sale
Chief Medical Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$3.00M
111K shares
What this filing means
RABEN DAVID plans to sell 111K shares of BICARA THERAPEUTICS INC. valued at approximately $3.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/8/2026ACC: 0001950047-26-006962
Officer· Chief Medical Officer
Since Mar 2026
111K
Shares to sell
$3.00M
Approx. market value
50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/8/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2026 | Stock Option Exercise Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
50K
Market value
$1.32M
6/25/2026
—Completed
Units to sell
5.50K
Market value
$118.7K
5/26/2026
—Completed
Units to sell
5.50K
Market value
$125.8K
4/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$1.43M
7/8/2026
Total
Units
111K
Value
$3.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 50K | $1.32M | — | Completed |
5/26/2026 | 5.50K | $118.7K | — | Completed |
4/27/2026 | 5.50K | $125.8K | — | Completed |
| Planned — Approximate Date | ||||
7/8/2026 | 50K | $1.43M | NASDAQ | Planned |
| Total | 111K | $3.00M | ||